Header Logo

Connection

JUN TERUYA to Female

Back to Details
This is a "connection" page, showing publications JUN TERUYA has written about Female.
JUN TERUYA
Connection Strength
0.479
Female
  1. Trimester-specific thromboelastic values and coagulation activation markers in pregnancy compared across trimesters and compared to the nonpregnant state. Int J Lab Hematol. 2021 Oct; 43(5):1216-1224.
    View in: PubMed
    Score: 0.029
  2. Low antithrombin levels in neonates and infants undergoing congenital heart surgery result in more red blood cell and plasma transfusion on cardiopulmonary bypass. Transfusion. 2020 12; 60(12):2841-2848.
    View in: PubMed
    Score: 0.028
  3. Acquired von Willebrand Syndrome in Pediatric Extracorporeal Membrane Oxygenation Patients: A Single Institution's Experience. Pediatr Crit Care Med. 2019 10; 20(10):980-985.
    View in: PubMed
    Score: 0.026
  4. Management of Hemostasis for Pediatric Patients on Ventricular-Assist Devices. Semin Thromb Hemost. 2018 Feb; 44(1):30-37.
    View in: PubMed
    Score: 0.023
  5. PIVKA-II correlates with INR but not protein C or protein S concentrations in cord blood among newborns. J Neonatal Perinatal Med. 2016 May 18; 9(2):139-43.
    View in: PubMed
    Score: 0.021
  6. The influence of free hemoglobin and bilirubin on heparin monitoring by activated partial thromboplastin time and anti-Xa assay. Arch Pathol Lab Med. 2014 Nov; 138(11):1503-6.
    View in: PubMed
    Score: 0.019
  7. Trends in parenteral direct thrombin inhibitor use in pediatric patients: analysis of a large administrative database. Arch Pathol Lab Med. 2014 Sep; 138(9):1229-32.
    View in: PubMed
    Score: 0.019
  8. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2014 Jun; 15(5):e198-205.
    View in: PubMed
    Score: 0.018
  9. Anticoagulation monitoring during extracorporeal membrane oxygenation: is anti-factor Xa assay (heparin level) a better test?*. Pediatr Crit Care Med. 2014 Feb; 15(2):178-9.
    View in: PubMed
    Score: 0.018
  10. Platelet function disorders and menorrhagia in adolescents: a review of laboratory diagnosis. J Pediatr Adolesc Gynecol. 2012 Aug; 25(4):233-7.
    View in: PubMed
    Score: 0.016
  11. Evaluation of blood supply operation and infectious disease markers in blood donors during the Egyptian revolution. Transfusion. 2012 Nov; 52(11):2321-8.
    View in: PubMed
    Score: 0.016
  12. Severe thrombotic and bleeding complications in a baby with heterozygous factor V Leiden and acquired von Willebrand disease on ECMO. J Extra Corpor Technol. 2011 Jun; 43(2):64-9.
    View in: PubMed
    Score: 0.015
  13. Evaluation of heparin assay for coagulation management in newborns undergoing ECMO. Am J Clin Pathol. 2010 Dec; 134(6):950-4.
    View in: PubMed
    Score: 0.014
  14. Development of factor V and thrombin inhibitors in children following bovine thrombin exposure during cardiac surgery: a report of three cases. Congenit Heart Dis. 2010 May-Jun; 5(3):303-8.
    View in: PubMed
    Score: 0.014
  15. Parameters of thromboelastography in healthy newborns. Am J Clin Pathol. 2008 Jul; 130(1):99-102.
    View in: PubMed
    Score: 0.012
  16. A practical approach to pediatric patients referred with an abnormal coagulation profile. Arch Pathol Lab Med. 2005 Aug; 129(8):1011-6.
    View in: PubMed
    Score: 0.010
  17. Thromboelastographic and hemostatic characteristics in pediatric patients with sickle cell disease. Arch Pathol Lab Med. 2005 Jun; 129(6):760-5.
    View in: PubMed
    Score: 0.010
  18. The Impact of Acute Exercise on Hemostasis and Angiogenesis Mediators in Patients With Continuous-Flow Left Ventricular Assist Devices: A Prospective Observational Pilot Study. ASAIO J. 2025 Jan 01; 71(1):11-20.
    View in: PubMed
    Score: 0.009
  19. Antiplatelet effect of aspirin in patients with cerebrovascular disease. Stroke. 2004 Jan; 35(1):175-8.
    View in: PubMed
    Score: 0.009
  20. Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH. J Thromb Haemost. 2022 07; 20(7):1735-1743.
    View in: PubMed
    Score: 0.008
  21. Blood, Sweat, and Fears: A Novel Mutation Associated With Anaphylaxis and Nonresponse in a Patient With Afibrinogenemia. J Pediatr Hematol Oncol. 2021 03 01; 43(2):e260-e263.
    View in: PubMed
    Score: 0.007
  22. Structural characterization of a clinically described heparin-like substance in plasma causing bleeding. Carbohydr Polym. 2020 Sep 15; 244:116443.
    View in: PubMed
    Score: 0.007
  23. Antithrombin Population Pharmacokinetics in Pediatric Ventricular Assist Device Patients. Pediatr Crit Care Med. 2019 12; 20(12):1157-1163.
    View in: PubMed
    Score: 0.007
  24. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team. Am J Obstet Gynecol. 2019 10; 221(4):337.e1-337.e5.
    View in: PubMed
    Score: 0.006
  25. Severe hypocalcemia during surgery for placenta accreta spectrum: The case for empiric replacement. Acta Obstet Gynecol Scand. 2019 10; 98(10):1326-1331.
    View in: PubMed
    Score: 0.006
  26. Coagulopathy in surgical management of placenta accreta spectrum. Eur J Obstet Gynecol Reprod Biol. 2019 Jun; 237:126-130.
    View in: PubMed
    Score: 0.006
  27. Centrifugal-flow ventricular assist device support in children: A single-center experience. J Thorac Cardiovasc Surg. 2019 04; 157(4):1609-1617.e2.
    View in: PubMed
    Score: 0.006
  28. Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience. Biol Blood Marrow Transplant. 2019 01; 25(1):157-162.
    View in: PubMed
    Score: 0.006
  29. ABO-incompatible deceased donor pediatric liver transplantation: Novel titer-based management protocol and outcomes. Pediatr Transplant. 2018 11; 22(7):e13263.
    View in: PubMed
    Score: 0.006
  30. Enoxaparin Population Pharmacokinetics in the First Year of Life. Ther Drug Monit. 2017 12; 39(6):632-639.
    View in: PubMed
    Score: 0.006
  31. Population Pharmacokinetics of Enoxaparin in Pediatric Patients. Ann Pharmacother. 2018 02; 52(2):140-146.
    View in: PubMed
    Score: 0.006
  32. Population pharmacokinetics of human antithrombin concentrate in paediatric patients. Br J Clin Pharmacol. 2017 Nov; 83(11):2450-2457.
    View in: PubMed
    Score: 0.006
  33. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over?time. Am J Obstet Gynecol. 2017 06; 216(6):612.e1-612.e5.
    View in: PubMed
    Score: 0.006
  34. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant. Pediatr Transplant. 2015 Jun; 19(4):391-8.
    View in: PubMed
    Score: 0.005
  35. Establishing thromboelastography with platelet-function analyzer reference ranges and other measures in healthy term pregnant women. Am J Perinatol. 2015 May; 32(6):545-54.
    View in: PubMed
    Score: 0.005
  36. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015 Feb; 212(2):218.e1-9.
    View in: PubMed
    Score: 0.005
  37. Age-related differences in urinary 11-dehydroxythromboxane B2 between infants, children, and adolescents: another example of developmental hemostasis? Pediatr Blood Cancer. 2014 Nov; 61(11):2074-6.
    View in: PubMed
    Score: 0.005
  38. Anticoagulation therapy trends in children supported by ventricular assist devices: a multi-institutional study. ASAIO J. 2014 Mar-Apr; 60(2):211-5.
    View in: PubMed
    Score: 0.004
  39. Granulocyte transfusions for children with infection and neutropenia or granulocyte dysfunction. Pediatr Hematol Oncol. 2014 Aug; 31(5):425-34.
    View in: PubMed
    Score: 0.004
  40. Platelet function defects in adolescents with heavy menstrual bleeding. Haemophilia. 2014 Mar; 20(2):249-54.
    View in: PubMed
    Score: 0.004
  41. Evaluation of the International Society on Thrombosis and Haemostasis and institutional diagnostic criteria of disseminated intravascular coagulation in pediatric patients. Am J Clin Pathol. 2013 Jun; 139(6):812-6.
    View in: PubMed
    Score: 0.004
  42. Utility of platelet function analyzer as a screening tool for the diagnosis of von Willebrand disease in adolescents with menorrhagia. Pediatr Blood Cancer. 2013 Jul; 60(7):1184-7.
    View in: PubMed
    Score: 0.004
  43. Coinfection with Staphylococcus aureus increases risk of severe coagulopathy in critically ill children with influenza A (H1N1) virus infection. Crit Care Med. 2012 Dec; 40(12):3246-50.
    View in: PubMed
    Score: 0.004
  44. Heparin dosing in obese pediatric patients in the cardiac catheterization laboratory. Ann Pharmacother. 2011 Jul; 45(7-8):876-80.
    View in: PubMed
    Score: 0.004
  45. Thrombotic microangiopathic hemolytic anemia with reduction of ADAMTS13 activity: initial manifestation of childhood-onset systemic lupus erythematosus. Am J Clin Pathol. 2011 Mar; 135(3):406-16.
    View in: PubMed
    Score: 0.004
  46. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease. Pediatr Blood Cancer. 2011 Aug; 57(2):294-6.
    View in: PubMed
    Score: 0.004
  47. Acquired von Willebrand syndrome and Wilms tumor: not always benign. Pediatr Blood Cancer. 2009 Mar; 52(3):392-4.
    View in: PubMed
    Score: 0.003
  48. Low prevalence and assay discordance of "aspirin resistance" in children. Pediatr Blood Cancer. 2008 Jul; 51(1):86-92.
    View in: PubMed
    Score: 0.003
  49. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics. 2006 May; 117(5):1673-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.